Role of AMPK in pancreatic beta cell function

Molecular and Cellular Endocrinology

Volumn 366, Issue 2, 2013, Pages 127-134

  Fu, Accalia ^a   Eberhard, Chandra E ^a   Screaton, Robert A ^a,b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

AMPK; Beta cell; Glucose stimulated insulin secretion; Islet; Mitochondria; Pancreas

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ACETYL COENZYME A CARBOXYLASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; COMPLEMENTARY DNA; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA 2; INSULIN; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; CELL PROLIFERATION; CELL SIZE; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME LOCALIZATION; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; REVIEW;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; DIABETES MELLITUS, TYPE 2; ENZYME ACTIVATION; GENE EXPRESSION; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; METFORMIN; MICE; MICE, KNOCKOUT;

EID: 84872660488     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.06.020     Document Type: Review

References (83)

1. Abbud W., et al. Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport. Arch. Biochem. Biophys. 2000, 380(2):347-352.
2. Akkan A.G., Malaisse W.J. Insulinotropic action of AICA riboside. I. Insulin release by isolated islets and the perfused pancreas. Diabetes Res. 1994, 25(1):13-23.
3. Baas A.F., et al. Complete polarization of single intestinal epithelial cells upon activation of Lkb1 by STRAD. Cell 2004, 116(3):457-466.
4. Barnes A.P., et al. Lkb1 and SAD kinases define a pathway required for the polarization of cortical neurons. Cell 2007, 129(3):549-563.
5. Barthel A., et al. Regulation of the forkhead transcription factor FKHR (FOXO1a) by glucose starvation and AICAR, an activator of AMP-activated protein kinase. Endocrinology 2002, 143(8):3183-3186.
6. Beall C., et al. Loss of AMP-activated protein kinase alpha2 subunit in mouse beta-cells impairs glucose-stimulated insulin secretion and inhibits their sensitivity to hypoglycaemia. Biochem. J. 2010, 429(2):323-333.
7. Cai Y., et al. Increased oxygen radical formation and mitochondrial dysfunction mediate beta cell apoptosis under conditions of AMP-activated protein kinase stimulation. Free Radic. Biol. Med. 2007, 42(1):64-78.
8. Claret M., et al. AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. J. Clin. Invest. 2007, 117(8):2325-2336.
9. da Silva Xavier G., et al. Role of AMP-activated protein kinase in the regulation by glucose of islet beta cell gene expression. Proc. Nat. Acad. Sci. USA 2000, 97(8):4023-4028.
10. da Silva Xavier G., et al. Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression. Biochem. J. 2003, 371(3):761-774.
11. DeFronzo R.A., Abdul-Ghani M.A. Preservation of beta-cell function: the key to diabetes prevention. J. Clin. Endocrinol. Metab. 2011, 96(8):2354-2366.
12. Detaille D., et al. Obligatory role of membrane events in the regulatory effect of metformin on the respiratory chain function. Biochem. Pharmacol. 2002, 63(7):1259-1272.
13. Diraison F., et al. Over-expression of sterol-regulatory-element-binding protein-1c (SREBP1c) in rat pancreatic islets induces lipogenesis and decreases glucose-stimulated insulin release: modulation by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR). Biochem. J. 2004, 378(Pt 3):769-778.
14. El-Mir M.Y., et al. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J. Biol. Chem. 2000, 275(1):223-228.
15. Fu A., et al. Loss of Lkb1 in adult beta cells increases beta cell mass and enhances glucose tolerance in mice. Cell Metab. 2009, 10(4):285-295.
16. Garcia-Garcia C., et al. AMPK-independent down-regulation of cFLIP and sensitization to TRAIL-induced apoptosis by AMPK activators. Biochem. Pharmacol. 2010, 79(6):853-863.
17. Garcia-Haro L., et al. The PP1-R6 protein phosphatase holoenzyme is involved in the glucose-induced dephosphorylation and inactivation of AMP-activated protein kinase, a key regulator of insulin secretion, in MIN6 beta cells. FASEB J. 2010, 24(12):5080-5091.
18. Gleason C.E., et al. The role of AMPK and mTOR in nutrient sensing in pancreatic beta-cells. J. Biol. Chem. 2007, 282(14):10341-10351.
19. Granot Z., et al. Lkb1 regulates pancreatic beta cell size, polarity, and function. Cell Metab. 2009, 10(4):296-308.
20. Hatlapatka K., Willenborg M., Rustenbeck I. Plasma membrane depolarization as a determinant of the first phase of insulin secretion. Am. J. Physiol. Endocrinol. Metab. 2009, 297(2):E315-E322.
21. Hawley S.A., et al. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 1996, 271(44):27879-27887.
22. Hawley S.A., et al. Complexes between the Lkb1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2003, 2(4):28.
23. Hawley S.A., et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2005, 2(1):9-19.
24. Hinke S.A., et al. Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer. Br. J. Pharmacol. 2007, 150(8):1031-1043.
25. Hurov J.B., et al. Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivo. Proc. Natl. Acad. Sci. USA 2007, 104(13):5680-5685.
26. Inoki K., et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 2006, 126(5):955-968.
27. Jansson D., et al. Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2. Proc. Natl. Acad. Sci. USA 2008, 105(29):10161-10166.
28. Jorgensen S.B., et al. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J. Biol. Chem. 2004, 279(2):1070-1079.
29. Kahn B.B., et al. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005, 1(1):15-25.
30. Kefas B.A., et al. AICA-riboside induces apoptosis of pancreatic beta cells through stimulation of AMP-activated protein kinase. Diabetologia 2003, 46(2):250-254.
31. Kefas B.A., et al. AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. J. Mol. Endocrinol. 2003, 30(2):151-161.
32. Kim W.H., et al. AICAR potentiates ROS production induced by chronic high glucose: roles of AMPK in pancreatic beta-cell apoptosis. Cell. Signal. 2007, 19(4):791-805.
33. Kurth-Kraczek E.J., et al. 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 1999, 48(8):1667-1671.
34. Lamontagne J., et al. Pioglitazone acutely reduces insulin secretion and causes metabolic deceleration of the pancreatic beta-cell at submaximal glucose concentrations. Endocrinology 2009, 150(8):3465-3474.
35. LeBrasseur N.K., et al. Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. Am. J. Physiol. Endocrinol. Metab. 2006, 291(1):E175-E181.
36. Leclerc I., Rutter G.A. AMP-activated protein kinase: a new beta-cell glucose sensor? Regulation by amino acids and calcium ions. Diabetes 2004, 53(Suppl 3):S67-S74.
37. Leclerc I., et al. Hepatocyte nuclear factor-4alpha involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase. Diabetes 2001, 50(7):1515-1521.
38. Leclerc I., et al. Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. Am. J. Physiol. Endocrinol. Metab. 2004, 286(6):E1023-E1031.
39. Lee J.H., et al. Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature 2007, 447(7147):1017-1020.
40. Lefebvre D.L., Rosen C.F. Regulation of SNARK activity in response to cellular stresses. Biochim. Biophys. Acta 2005, 1724(1-2):71-85.
41. Lennerz J.K., et al. Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesis. Mol. Cell. Biol. 2010, 30(21):5043-5056.
42. Li Y., et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011, 13(4):376-388.
43. Lim A., et al. Glucose deprivation regulates KATP channel trafficking via AMP-activated protein kinase in pancreatic beta-cells. Diabetes 2009, 58(12):2813-2819.
44. Lizcano J.M., et al. Lkb1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 2004, 23(4):833-843.
45. MacDonald P.E., Eliasson L., Rorsman P. Calcium increases endocytotic vesicle size and accelerates membrane fission in insulin-secreting INS-1 cells. J. Cell Sci. 2005, 118(Pt 24):5911-5920.
46. MacDonald P.E., et al. Regulated exocytosis and kiss-and-run of synaptic-like microvesicles in INS-1 and primary rat beta-cells. Diabetes 2005, 54(3):736-743.
47. Malaisse W.J., et al. Insulinotropic action of AICA riboside. II. Secretory, metabolic and cationic aspects. Diabetes Res 1994, 25(1):25-37.
48. Momcilovic M., Hong S.P., Carlson M. Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J. Biol. Chem. 2006, 281(35):25336-25343.
49. Nyblom H.K., Sargsyan E., Bergsten P. AMP-activated protein kinase agonist dose dependently improves function and reduces apoptosis in glucotoxic beta-cells without changing triglyceride levels. J. Mol. Endocrinol. 2008, 41(3):187-194.
50. Oakhill J.S., et al. AMPK is a direct adenylate charge-regulated protein kinase. Science 2011, 332(6036):1433-1435.
51. Pold R., et al. Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes 2005, 54(4):928-934.
52. Rachdi L., et al. Disruption of Tsc2 in pancreatic beta cells induces beta cell mass expansion and improved glucose tolerance in a TORC1-dependent manner. Proc. Natl. Acad. Sci. USA 2008, 105(27):9250-9255.
53. Richards S.K., et al. Over-expression of AMP-activated protein kinase impairs pancreatic {beta}-cell function in vivo. J. Endocrinol. 2005, 187(2):225-235.
54. Ronnebaum S.M., et al. Chronic suppression of acetyl-CoA carboxylase 1 in beta-cells impairs insulin secretion via inhibition of glucose rather than lipid metabolism. J. Biol. Chem. 2008, 283(21):14248-14256.
55. Ruderman N.B., et al. Malonyl-CoA, fuel sensing, and insulin resistance. Am. J. Physiol. 1999, 276(1 Pt 1):E1-E18.
56. Rutter G.A., Da Silva Xavier G., Leclerc I. Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem. J. 2003, 375(Pt 1):1-16.
57. Salt I., et al. AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform. Biochem. J. 1998, 334(Pt 1):177-187.
58. Salt I.P., et al. AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. Biochem. J. 1998, 335(Pt 3):533-539.
59. Santidrian A.F., et al. AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells. Blood 2010, 116(16):3023-3032.
60. Sasaki T., et al. SIK2 is a key regulator for neuronal survival after ischemia via TORC1-CREB. Neuron 2011, 69(1):106-119.
61. Shaw R.J., et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005, 310(5754):1642-1646.
62. Shigeyama Y., et al. Biphasic response of pancreatic beta-cell mass to ablation of tuberous sclerosis complex 2 in mice. Mol. Cell. Biol. 2008, 28(9):2971-2979.
63. Song X.M., et al. 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice. Diabetologia 2002, 45(1):56-65.
64. Sun G., et al. Lkb1 deletion with the RIP2.Cre transgene modifies pancreatic beta-cell morphology and enhances insulin secretion in vivo. Am. J. Physiol. Endocrinol. Metab. 2010, 298(6):E1261-E1273.
65. Sun G., et al. Ablation of AMP-activated protein kinase alpha1 and alpha2 from mouse pancreatic beta cells and RIP2.Cre neurons suppresses insulin release in vivo. Diabetologia 2010, 53(5):924-936.
66. Targonsky E.D., et al. Alpha-lipoic acid regulates AMP-activated protein kinase and inhibits insulin secretion from beta cells. Diabetologia 2006, 49(7):1587-1598.
67. Tsuboi T., et al. 5'-AMP-activated protein kinase controls insulin-containing secretory vesicle dynamics. J. Biol. Chem. 2003, 278(52):52042-52051.
68. Van de Casteele M., et al. Prolonged culture in low glucose induces apoptosis of rat pancreatic beta-cells through induction of c-myc. Biochem. Biophys. Res. Commun. 2003, 312(4):937-944.
69. Vincent M.F., et al. Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes. Diabetes 1991, 40(10):1259-1266.
70. Viollet B., et al. Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem. Soc. Trans. 2003, 31(Pt 1):216-219.
71. Wang C.Z., et al. 5-amino-imidazole carboxamide riboside acutely potentiates glucose-stimulated insulin secretion from mouse pancreatic islets by KATP channel-dependent and -independent pathways. Biochem. Biophys. Res. Commun. 2005, 330(4):1073-1079.
72. Wang X., et al. Troglitazone acutely activates AMP-activated protein kinase and inhibits insulin secretion from beta cells. Life Sci. 2007, 81(2):160-165.
73. Watts J.L., et al. The C. elegans par-4 gene encodes a putative serine-threonine kinase required for establishing embryonic asymmetry. Development 2000, 127(7):1467-1475.
74. Wicksteed B., et al. Conditional gene targeting in mouse pancreatic ss-Cells: analysis of ectopic Cre transgene expression in the brain. Diabetes 2010, 59(12):3090-3098.
75. Wiederkehr A., Wollheim C.B. Impact of mitochondrial calcium on the coupling of metabolism to insulin secretion in the pancreatic beta-cell. Cell Calcium 2008, 44(1):64-76.
76. Woods A., et al. Lkb1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 2003, 13(22):2004-2008.
77. Woods A., et al. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005, 2(1):21-33.
78. Xiao B., et al. Structure of mammalian AMPK and its regulation by ADP. Nature 2011, 472(7342):230-233.
79. Xue B., Kahn B.B. AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues. J. Physiol. 2006, 574(Pt 1):73-83.
80. Zhang S., Kim K.H. Glucose activation of acetyl-CoA carboxylase in association with insulin secretion in a pancreatic beta-cell line. J. Endocrinol. 1995, 147(1):33-41.
81. Zhang B.B., Zhou G., Li C. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 2009, 9(5):407-416.
82. Zhang X., et al. AMP-activated protein kinase and pancreatic/duodenal homeobox-1 involved in insulin secretion under high leucine exposure in rat insulinoma beta-cells. J. Cell Mol. Med. 2009, 13(4):758-770.
83. Zhou L., et al. Berberine acutely inhibits insulin secretion from beta-cells through 3',5'-cyclic adenosine 5'-monophosphate signaling pathway. Endocrinology 2008, 149(9):4510-4518.